A middle aged female presented with a solitary thyroid nodule of size 2 cm. What is the next line of management?
**Core Concept**
The management of a solitary thyroid nodule involves evaluating its potential for malignancy and determining the appropriate diagnostic and therapeutic approach. **Thyroid nodules** are common and can be benign or malignant. The size of the nodule is an important factor in determining the next steps.
**Why the Correct Answer is Right**
Given the nodule is 2 cm, the next step typically involves further evaluation to assess for malignancy. This usually starts with **thyroid function tests** to determine if the nodule is functioning (hot) or non-functioning (cold), and **ultrasound** to assess the nodule's characteristics and guide potential **fine-needle aspiration biopsy (FNAB)** if suspicious features are present.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because immediate surgery is not typically the first step without first assessing the nodule's characteristics and function.
**Option B:** Incorrect as not all solitary nodules require immediate biopsy; the approach depends on the nodule's size, patient's symptoms, and ultrasound features.
**Option C:** Incorrect because while ultrasound is part of the evaluation, it's not the only step, and the question asks for the next line of management, implying a more comprehensive approach is needed.
**Option D:** Incorrect as this option is not provided, but typically, the next step after identifying a solitary thyroid nodule involves a combination of diagnostic tests.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that the size of the nodule, patient's age, sex, and ultrasound features guide the decision for biopsy. The **American Thyroid Association (ATA)** guidelines provide a framework for the management of thyroid nodules, including when to perform biopsy based on nodule size and suspicious features.
**Correct Answer:** D. Fine-needle aspiration biopsy (FNAB) for nodules ≥1 cm with suspicious ultrasound features or ≥1.5 to 2 cm without suspicious features, but the exact next step can depend on specific clinical guidelines and patient factors, and since the options are not fully provided, the general approach for a 2 cm nodule typically involves further evaluation as described.